A Study Of Precure Prospective

Overview

About this study

The purpose of this study is to better understand and predict biological processes before disease onset, to study the host and environmental contributors to disease, to effectively intervene in disease processes before they become serious and complex, and to develop biologically targeted therapies for disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Prior to Baseline Specimen Collection:

  • Age ≥ 18 years

  • Registered Mayo Clinic patient

  • Able to provide informed consent

Inclusion Criteria - After Baseline Specimen Collection:

  • Age ≥ 18 years

  • Registered Mayo Clinic patient

Exclusion Criteria - Prior to Baseline Specimen Collection:

  • Active hematological cancer or history of a hematological cancer

  • Allogeneic Bone Marrow Transplant (autologous bone marrow transplant acceptable if specimens collected at least one month after transplant)

  • Other co-morbidity that, in physician’s opinion, would interfere with patient’s ability to participate in the study

Exclusion Criteria - After Baseline Specimen Collection:

  • Co-morbidity that, in physician’s opinion, would interfere with patient’s ability to participate in the study

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/23/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Lazaridis, M.D.

Open for enrollment

Contact information:

TARGET Study Team

MayoClinicTARGET@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Victor Ortega, M.D., Ph.D.

Contact us for the latest status

Contact information:

TARGET Study Team

MayoClinicTARGET@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Richard Presutti, D.O., FAAFP

Contact us for the latest status

Contact information:

TARGET Study Team

MayoClinicTARGET@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20605762

Mayo Clinic Footer